| Old Articles: <Older 7291-7300 Newer> |
|---|
 |
Registered Rep.
March 15, 2006
Kevin Burke |
Merrill Fined $2.5 Million Over Lax Email Oversight The SEC slapped the nation's largest brokerage with a $2.5 million fine and a cease-and-desist order for a "systemic" mishandling of email records related to its brokerage business.   |
The Motley Fool
March 15, 2006
Brian Gorman |
Airbus' Chinese Fortune Airbus' investment in China is a shortsighted strategy. Investors, take note. |
The Motley Fool
March 15, 2006
Alyce Lomax |
It's Showtime at AOL In2TV debuts, with big-name advertisers in tow. When it comes to showing video on the Web, AOL may finally be tuning in. |
The Motley Fool
March 15, 2006
Selena Maranjian |
Women on Board? Not So Many. Boards of directors seem to have trouble finding women. Here's a possible reason why, and why it matters to investors. |
The Motley Fool
March 14, 2006
David Gardner |
The King of Online Bling In this interview, amid talk of business, P/Es, and stock options, the co-founder and CEO of Blue Nile reveals how he hopes to be (and remain) a shareholder's best friend. |
The Motley Fool
March 14, 2006
Alyce Lomax |
Google Turns the Page The search giant comes up with a way to show book publishers the money. Meanwhile, it could get Google out of the hot seat when it comes to the controversial topic of digital copyright -- something Google investors certainly want to see. |
The Motley Fool
March 14, 2006
Rick Aristotle Munarriz |
All the Quotes Aren't Fit to Print Sending its users online for stock quotes exposes the publisher to rival sources for news that are a click away. Once smitten with the Internet's access to news as it breaks, will they go ever back to the printed page? Investors, take note. |
AFP eWire
March 13, 2006 |
AFP Leaders Attend White House Philanthropy Conference The purpose of the conference was to emphasize the important role that corporations and foundations play in funding social services. The White House also released data showing federal discretionary grant activity with faith-based charities in 2005. |
Bio-IT World
March 2006
John Russell |
Genzyme's Guerilla Informatics Whether by wisdom or necessity, Genzyme didn't fall prey to industry infatuation with bioinformatics tools. |
Bio-IT World
March 2006
John Russell |
It's All About the Drugs A conversation with biopharma Organon's executive VP for global research and development highlights how, regardless of the company's enthusiasm for new technology, it is first and foremost interested in pharmacology and medicinal chemistry -- drugs. |
| <Older 7291-7300 Newer> Return to current articles. |
